Zeitz M, Hope U, Wust B, Galanos C, Möller B, Lawley T J, Riecken E O
Department of Medicine, Klinikum Steglitz, Free University Berlin, FRG.
Gut. 1987 Nov;28(11):1460-6. doi: 10.1136/gut.28.11.1460.
Complement fixing antibodies against different Escherichia coli lipopolysaccharides were determined in patients with Crohn's disease and in healthy individuals and compared with antitetanus toxoid antibodies. All healthy individuals had antilipopolysaccharide antibodies, 10 of 27 patients with Crohn's disease had no antibodies and six had rapidly changing antibody titres. These abnormalities were found in patients with disease in the colon, with arthropathy and fistula. Antilipid A was found at lower titres in Crohn's disease. Neither antitetanus toxoid antibodies, nor immunoglobulin concentrations were different in patients with or without antilipopolysaccharide antibodies. There was no evidence for circulating immune complexes in patients lacking antilipopolysaccharide antibodies. Certain subgroups of patients with Crohn's disease have altered antibody levels to typical enteral antigens which most likely can be explained by local antibody binding to lipopolysaccharides at inflammatory sites, or by changes in immunoregulation in this disease.
在克罗恩病患者和健康个体中测定了针对不同大肠杆菌脂多糖的补体结合抗体,并与抗破伤风类毒素抗体进行了比较。所有健康个体均有抗脂多糖抗体,27例克罗恩病患者中有10例无抗体,6例抗体滴度迅速变化。这些异常在患有结肠疾病、关节病和瘘管的患者中被发现。在克罗恩病中发现抗脂质A的滴度较低。有无抗脂多糖抗体的患者的抗破伤风类毒素抗体和免疫球蛋白浓度均无差异。缺乏抗脂多糖抗体的患者没有循环免疫复合物的证据。某些克罗恩病患者亚组对典型肠内抗原的抗体水平发生了改变,这很可能可以通过炎症部位局部抗体与脂多糖结合,或通过该疾病免疫调节的变化来解释。